OxTalks will soon move to the new Halo platform and will become 'Oxford Events.' There will be a need for an OxTalks freeze. This was previously planned for Friday 14th November – a new date will be shared as soon as it is available (full details will be available on the Staff Gateway).
In the meantime, the OxTalks site will remain active and events will continue to be published.
If staff have any questions about the Oxford Events launch, please contact halo@digital.ox.ac.uk
Epidemics and pandemics of novel pathogens are often characterized by a lack of known therapeutic or preventive interventions. It is therefore imperative to rapidly conduct research to study and develop countermeasures in these contexts. Yet, with research underway and no ‘proven’ therapeutic or preventive interventions, a question exists as to whether individuals, groups, or populations should be offered ‘unproven’ preventive and/or therapeutic interventions outside of clinical trials, including “off-label” interventions. This seminar will explore the use of ‘unproven’ clinical interventions during public health emergencies, coinciding with the recent publication of the World Health Organization’s guidance document, “Emergency use of unproven clinical interventions outside clinical trials: ethical considerations”.
Chair:
Prof. Ross Upshur, Head, Division of Clinical Public Health, Dalla Lana School of Public Health, University of Toronto, Canada
Panel:
